Browse > Article
http://dx.doi.org/10.7845/kjm.2019.9082

Anti-inflammatory activity of Eurya persicifolia Gagnep. extract in Propionibacterium acnes-induced inflammatory signaling by regulation of NF-κB activity  

Shin, Jin Hak (Department of Molecular Bioscience, College of Biomedical Science, Institute of Bioscience & Biotechnology, Kangwon National University)
Seo, Su Ryeon (Department of Molecular Bioscience, College of Biomedical Science, Institute of Bioscience & Biotechnology, Kangwon National University)
Publication Information
Korean Journal of Microbiology / v.55, no.3, 2019 , pp. 213-219 More about this Journal
Abstract
Acne is a chronic inflammatory disease outbreak in the sebaceous glands within the hair follicle. The proliferation of Propionibacterium acnes (P. acnes) causes monocytes to stimulate secretion of inflammatory cytokines. A number of studies proposed the inhibitory effects of P. acnes-mediated inflammation by several natural extracts. However, studies on the effect of Eurya persicifolia Gagnep. (E. persicifolia) extracts on the inflammatory responses by P. acnes have not been explored yet. In this study, we investigated the anti-inflammatory effect of E. persicifolia extract in the inflammatory reactions induced by P. acnes. We found that E. persicifolia extract successfully diminished the expression levels of inflammatory mediators such as IL-$1{\beta}$, IL-6, TNF-${\alpha}$, and iNOS in P. acnes-activated mouse macrophage RAW 264.7 cells. We found that the immunosuppressive effect of E. persicifolia extract in the P. acnes-activated inflammatory signaling is mediated by the regulation of NF-${\kappa}B$ transcriptional activation, which is a key regulator of inflammatory cytokine expression. Our results suggest that E. persicifolia extract held potentials for the treatment of P. acnes by suppressing NF-${\kappa}B$ signaling pathways.
Keywords
E. persicifolia Gagnep.; Propionibacterium acnes; acne; inflammation; pro-inflammatory cytokine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wang YY, Ryu AR, Jin S, Jeon YM, and Lee MY. 2017. Chlorin e6-mediated photodynamic therapy suppresses P. acnes-induced inflammatory response via $NF{\kappa}B$ and MAPKs signaling pathway. PLoS One 12, e0170599.   DOI
2 Webster GF and Leyden JJ. 1980. Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation 4, 261-269.   DOI
3 Yang Kuo LM, Zhang LJ, Huang HT, Lin ZH, Liaw CC, Cheng HL, Lee KH, Morris-Natschke SL, Kuo YH, and Ho HO. 2013. Antioxidant lignans and chromone glycosides from Eurya japonica. J. Nat. Prod. 76, 580-587.   DOI
4 Yoon CS, Kim HJ, Lim HW, Kim BH, Kim HS, and Choi SW. 2006. Studies on the anti-acne effect of Agrimonia pilosa Ledeb. J. Soc. Cosmet. Sci. Korea 32, 53-58.
5 Bonizzi G and Karin M. 2004. The two NF-${\kappa}B$ activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.   DOI
6 Grange PA, Raingeaud J, Calvez V, and Dupin N. 2009. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-${\kappa}B$ and MAPK pathways. J. Dermatol. Sci. 56, 106-112.   DOI
7 Libermann TA and Baltimore D. 1990. Activation of interleukin-6 gene expression through the NF-${\kappa}B$ transcription factor. Mol. Cell. Biol. 10, 2327-2334.   DOI
8 Heymann WR. 2006. Toll-like receptors in acne vulgaris. J. Am. Acad. Dermatol. 55, 691-692.   DOI
9 Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, and Dreno B. 2005. Induction of toll-like receptors by Propionibacterium acnes. Br. J. Dermatol. 153, 1105-1113.   DOI
10 Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, and Akira S. 2002. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 169, 1535-1541.   DOI
11 Liu T, Zhang L, Joo D, and Sun SC. 2017. NF-${\kappa}B$ signaling in inflammation. Signal Transduct. Target Ther. 2, 17023.   DOI
12 Suh DH. 2010. Pharmacologic treatment of acne. J. Korean Med. Assoc. 53, 623-629.   DOI
13 Motooka R, Usami A, Nakahashi H, Koutari S, Nakaya S, Shimizu R, Tsuji K, Marumoto S, and Miyazawa M. 2015. Characteristic odor components of essential oils from Eurya japonica. J. Oleo Sci. 64, 577-584.   DOI
14 Murray PJ and Wynn TA. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723.   DOI
15 Omer H, McDowell A, and Alexeyev OA. 2017. Understanding the role of Propionibacterium acnes in acne vulgaris: The critical importance of skin sampling methodologies. Clin. Dermatol. 35, 118-129.   DOI
16 Park J, Lee J, Jung E, Park Y, Kim K, Park B, Jung K, Park E, Kim J, and Park D. 2004. In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur. J. Pharmacol. 496, 189-195.   DOI
17 Rosalind T, Dutta B, and Paul S. 2013. Evaluation of in vitro antioxidant activity, estimation of total phenolic and flavonoid content of leaf extract of Eurya japonica Thunb. Asian J. Pharm. Clin. Res. 6, 152-155.
18 Suh DH and Kwon H. 2015. What's new in the physiopathology of acne? British J. Dermatol. 172, 13-19.
19 Swanson JK. 2003. Antibiotic resistance of Propionibacterium acnes in acne vulgaris. Dermatol. Nurs. 15, 359-363.
20 Tan HH. 2003. Antibacterial therapy for acne. Am. J. Clin. Dermatol. 4, 307-314.   DOI
21 Thiboutot DM, Layton AM, and Eady EA. 2014. IL-17: A key player in the P. acnes inflammatory cascade? J. Invest. Dermatol. 134, 307-310.   DOI
22 Thingbaijam R, Dutta B, and Paul S. 2011. Phytochemical screening and antibacterial studies of the leaf extract of Eurya japonica Thunb. and Ficus auriculata Lour. J. Pure Appl. Microbiol. 5, 909-916.